期刊文献+

淋巴结阴性进展期胃癌复发的模式和影响因素的回顾性研究 被引量:9

原文传递
导出
摘要 目的探讨淋巴结阴性进展期胃癌根治性切除术后发生复发的模式和影响因素,用以评估预后和改进治疗策略。方法对2000~2006年淋巴结阴性并且接受根治性切除术的590例进展期胃癌患者的临床病理特征和预后进行回顾性评价。结果在纳入研究的590例患者中,有28例(4.7%)发生局部复发,10例(1.7%)发生淋巴结复发,52例(8.8%)发生腹膜种植转移,41例(6.9%)发生血行转移。通过多因素分析我们发现,肿瘤最大直径(P=0.021),组织学类型(P=0.000)和Borrmann分型(P=0.035)是影响局部复发的独立性因素。淋巴结清扫术(P=0.033)和脉管浸润(P=0.006)对淋巴结复发有显著影响。影响腹膜种植转移的临床病理因素有浸润深度(P=0.000)和Borrmann分型(P=0.004)。此外,脉管浸润(P=0.015)和组织学类型(P=0.000)与血行转移有显著相关性。结论淋巴结阴性进展期胃癌更容易发生腹膜种植转移和血行转移。
出处 《中华临床医师杂志(电子版)》 CAS 2010年第12期115-118,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 沈阳科学技术计划项目(1071166-9-00) 沈阳科学技术计划项目(1081232-1-00)
  • 相关文献

参考文献18

  • 1Bittoni A,Maccaroni E,Scartozzi M,et al.Chemotherapy for locally advanced and metastatic gastric cancer:state of the art and future erspectives.Eur Rev Med Pharmacol Sci,2010,14(4):309-314.
  • 2Wong R,Cunningham D.Optimising treatment regimens for the management of advanced gastric cancer.Ann Oncol,2009,20 (4):605-608.
  • 3Jackson C,Cunningham D,Oliveira J,et al.Gastric cancer:ESMO clinical recommendations for diagnosis,treatment and follow-up.Ann Oncol,2009,20 Suppl 4:34-36.
  • 4Lai JF,Kim S,Kim K,et al.Prediction of recurrence of early gastric cancer after curative resection.Ann Surg Oncol,2009,16(7):1896-1902.
  • 5Adachi Y,Mori M,Maehara Y,et al.Prognostic factors of node-negative gastric carcinoma:univariate and multivariate analyses.J Am Coll Surg,1997,184(4):373-377.
  • 6Bruno L,Nesi G,Montinaro F,et al.Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer.J Surg Oncol,2000,74(1):30-32.
  • 7Hyung WJ,Lee JH,Choi SH,et al.Prognostic impact of lymphatic and /or blood vessel invasion in patients with node-negative advanced gastric ancer.Ann Surg Oncol,2002,9(6):562-567.
  • 8Maehara Y,Tomoda M,Tomisaki S,et al.Surgical treatment and outcome for node-negative gastric cancer.Surgery,1997,121(6):633-639.
  • 9Kooby DA,Suriawinata A,Klimstra DS,et al.Biologic predictors of survival in node-negative gastric cancer.Ann Surg,2003,237 (6):835-837.
  • 10Greene FL,Page DL,Fleming ID,et al.AJCC Cancer Staging Manual.6th ed.New York:Springer,2002.

同被引文献71

  • 1张勤,叶再元,余建法,张瑞麟,徐继,叶圣雅,张琪.胃次全切除后残胃-十二指肠-连续性空肠间置术的临床研究[J].中华医学杂志,2005,85(30):2117-2119. 被引量:11
  • 2Smedh U,Hansson L,Ekman R,et al.Total gastrectomy causes a sustained,long-term elevation of somatostatin in plasma,independent of the mode of reconstruction in pigs. In Vivo . 2009
  • 3Kurita N,Shimada M,Chikakiyo M,et al.Does Roux-en Y reconstruction with jejunal pouch after total gastrectomy prevent complications of post-gastrectomy. Hepato Gastroenterology . 2008
  • 4Ikeguchi M,Kuroda H,Saito H,et al.A new pouch reconstruction method after total gastrectomy(pouch-double tract method)improved the postop-erative quality of life of patients with gastric cancer. Langenbecks Archive of Surgery . 2011
  • 5Buchwald H,Kellogg TA,Leslie DB,et al.Duodenal switch operative mortality and morbidity are not impacted by body mass index. Annals of Surgery . 2008
  • 6Piessen G,Triboulet JP,Mariette C.Reconstruction after gas-trectomy:Which technique is best?. J Visc Surg . 2010
  • 7Ishigami S,Aridome K,Nakajo A,et al.Roux-en-Y reconstructionwith stapled distal jejunal pouch after total gastrectomy. The American Surgeon . 2010
  • 8Lehnert T,Buhl K.Techniques of reconstruction after total gastrectomy for cancer. British Journal of Surgery . 2004
  • 9Gertler R,Rosenberg R,Feith M, et al.Pouch vs. no pouch following total gastrectomy:meta-analysis and systematic review. The American journal of Gastroenterology . 2009
  • 10Tomoda A,Miyazawa K,Tabuchi T.Prevention of carcinogenesis and development of gastric and colon cancers by2-aminophenoxazine-3-one(Phx-3):direct and indirect anti-cancer activity of Phx-3[J].Int J Mol Sci,2013,14(9):17573-17583.

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部